↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Murin L) srt2:(2015-2019)"

Search: WFRF:(Murin L) > (2015-2019)

Result 1-10 of 10

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
2.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
3.	Ridker, PM, et al. (author) Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients 2017 In: The New England journal of medicine. - 1533-4406 .- 0028-4793. ; 376:16, s. 1527-1539 Journal article (peer-reviewed)
4.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
5.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
6.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
7.	Goodman, SG, et al. (author) Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1177-1186 Journal article (peer-reviewed)
8.	Schwartz, GG, et al. (author) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome 2018 In: The New England journal of medicine. - : MASSACHUSETTS MEDICAL SOC. - 1533-4406 .- 0028-4793. ; 379:22, s. 2097-2107 Journal article (peer-reviewed)
9.	Kapelios, CJ, et al. (author) Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2019 In: European journal of heart failure. - : Wiley. - 1879-0844 .- 1388-9842. ; 21:11, s. 1383-1397 Journal article (peer-reviewed)
10.	Vaqueiro-Contreras, Michelle, et al. (author) Powerful recombination centers resulting from reactions of hydrogen with carbon–oxygen defects in n-type Czochralski-grown silicon 2017 In: Physica Status Solidi. Rapid Research Letters. - : John Wiley & Sons. - 1862-6254 .- 1862-6270. ; 11:8 Journal article (peer-reviewed)abstract It has been acknowledged for over 50 years that treatments with hydrogen can improve silicon semiconductor devices. In recent years, these have been used to an advantage in silicon solar cells reducing the loss of photo-generated carriers at the silicon surface or at the silicon interface with dielectrics. However, we have found that in some types of silicon the in-diffusion of hydrogen can result in the formation of powerful recombination centers composed of carbon, oxygen, and hydrogen which reduce the carrier lifetime and ultimately the efficiency of solar cells made from such material

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 10

Refine your search

Type of publication: journal article (10)

Type of content: peer-reviewed (10)

Author/Editor: Murin, J (9); Li, Y. (8); Schmidt, E. (8); Seferovic, P (8); Katz, A. (8); Ilic, S. (8); show more...; Jukema, JW (8); Kim, C. (8); Malik, A (8); Ristic, AD (8); Fazekas, F. (8); Ferrari, E. (8); Filardi, PP (8); Mach, F (8); Müller, C. (8); Witt, N (8); Shechter, M (8); Merkely, B (8); Probst, V. (8); Fras, Z (8); Laufs, U (8); Baranova, E (8); de Silva, HA (8); Stellbrink, C (8); Dion, D (8); Kim, SH (8); Rasmanis, G (8); Aylward, PE (8); Moriarty, PM (8); Erglis, A (8); Karpov, Y (8); Tunon, J (8); Chiang, CE (8); Sritara, P (8); Caccavo, A (8); Mackinnon, IJ (8); Codutti, OR (8); Jure, HO (8); Zaidman, CJ (8); Vico, ML (8); Carnero, GS (8); Colombo, HR (8); Luquez, HA (8); Colquhoun, D (8); Carroll, PA (8); Faes, D (8); Hermans, K (8); De Wolf, L (8); Vervoort, G (8); Roosen, J (8); show less...

University: Karolinska Institutet (9); Uppsala University (7); Luleå University of Technology (1); Lund University (1)

Language: English (10)

Research subject (UKÄ/SCB): Medical and Health Sciences (8); Natural sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view